-
1
-
-
0020363575
-
-
W. Bauer, U. Briner, W. Doepfner, R. Haller, R. Huguenin, P. Marbach, T.J. Petcher, and J. Pless Life Sci. 31 1982 1133 1140
-
(1982)
Life Sci.
, vol.31
, pp. 1133-1140
-
-
Bauer, W.1
Briner, U.2
Doepfner, W.3
Haller, R.4
Huguenin, R.5
Marbach, P.6
Petcher, T.J.7
Pless, J.8
-
2
-
-
0029989477
-
-
D.A. Pearson, J. Lister-James, W.J. McBride, D.M. Wilson, L.J. Martel, E.R. Civitello, J.E. Taylor, B.R. Moyer, and R.T. Dean J. Med. Chem. 39 1996 1361 1371
-
(1996)
J. Med. Chem.
, vol.39
, pp. 1361-1371
-
-
Pearson, D.A.1
Lister-James, J.2
McBride, W.J.3
Wilson, D.M.4
Martel, L.J.5
Civitello, E.R.6
Taylor, J.E.7
Moyer, B.R.8
Dean, R.T.9
-
3
-
-
0027517429
-
-
E.P. Krenning, D.J. Kwekkeboom, W.H. Bakker, W.A.P. Breeman, P.P.M. Kooji, H.Y. Oei, M. van Hagen, P.T.E. Postema, M. de Jong, J.C. Reubi, T.J. Visser, A.E.M. Reijs, L.J. Hofland, J.W. Koper, and S.W.J. Lamberts Eur. J. Nucl. Med. 20 1993 716 731 and references cited therein
-
(1993)
Eur. J. Nucl. Med.
, vol.20
, pp. 716-731
-
-
Krenning, E.P.1
Kwekkeboom, D.J.2
Bakker, W.H.3
Breeman, W.A.P.4
Kooji, P.P.M.5
Oei, H.Y.6
Van Hagen, M.7
Postema, P.T.E.8
De Jong, M.9
Reubi, J.C.10
Visser, T.J.11
Reijs, A.E.M.12
Hofland, L.J.13
Koper, J.W.14
Lamberts, S.W.J.15
-
4
-
-
0033594253
-
-
J.S. Lewis, M.R. Lewis, A. Srinivasan, M.A. Schmidt, J. Wang, and C.J. Anderson J. Med. Chem. 42 1999 1341 1347
-
(1999)
J. Med. Chem.
, vol.42
, pp. 1341-1347
-
-
Lewis, J.S.1
Lewis, M.R.2
Srinivasan, A.3
Schmidt, M.A.4
Wang, J.5
Anderson, C.J.6
-
5
-
-
9644304332
-
-
note
-
1/2 = 16.9 h and beta emission, 2.11 MeV) are ideal for therapy
-
-
-
-
6
-
-
0036596881
-
-
T. Maina, B. Nock, A. Nikolopoulou, P. Sotiriou, G. Loudos, D. Maintas, P. Cordopatis, and E. Choitellis Eur. J. Nucl. Med. 29 2002 742 753
-
(2002)
Eur. J. Nucl. Med.
, vol.29
, pp. 742-753
-
-
Maina, T.1
Nock, B.2
Nikolopoulou, A.3
Sotiriou, P.4
Loudos, G.5
Maintas, D.6
Cordopatis, P.7
Choitellis, E.8
-
9
-
-
0242408216
-
-
P. Grieco, P. Campiglia, I. Gomez-Monterrey, T. Lama, and E. Novellino Synlett 2003 2216 2218 and references cited therein
-
(2003)
Synlett
, pp. 2216-2218
-
-
Grieco, P.1
Campiglia, P.2
Gomez-Monterrey, I.3
Lama, T.4
Novellino, E.5
-
10
-
-
1642456650
-
-
P. Campiglia, I. Gomez-Monterrey, L. Longobardo, T. Lama, E. Novellino, and P. Grieco Tetrahedron Lett. 45 2004 1453 1456 and references cited therein
-
(2004)
Tetrahedron Lett.
, vol.45
, pp. 1453-1456
-
-
Campiglia, P.1
Gomez-Monterrey, I.2
Longobardo, L.3
Lama, T.4
Novellino, E.5
Grieco, P.6
-
16
-
-
0034746687
-
-
Intolerance of catalysts to basic functionality has been previously reported. T.M. Trnka, and R.H. Grubbs Acc. Chem. Res. 34 2001 18 29
-
(2001)
Acc. Chem. Res.
, vol.34
, pp. 18-29
-
-
Trnka, T.M.1
Grubbs, R.H.2
-
23
-
-
0035838887
-
-
H.E. Blackwell, J.D. Sadowsky, R.J. Howard, J.N. Samson, J.A. Chao, W.E. Steinmetz, D.J. O'Leary, and R.H. Grubbs J. Org. Chem. 66 2001 5291 5302
-
(2001)
J. Org. Chem.
, vol.66
, pp. 5291-5302
-
-
Blackwell, H.E.1
Sadowsky, J.D.2
Howard, R.J.3
Samson, J.N.4
Chao, J.A.5
Steinmetz, W.E.6
O'Leary, D.J.7
Grubbs, R.H.8
-
26
-
-
9644290589
-
-
note
-
The unit cell of octreotide contains three individual molecules of the peptide. Only one molecule (Molecule II) possesses the rotomer conformation believed to be associated with biological activity. This molecule was modelled using Insight II with the Discover Minimisation Module (Accelerys: San Diego, C.A.; 1996, Vol. 2002)
-
-
-
|